The Latin America, Middle East and Africa Herpes Simplex Virus Treatment Market should witness market growth of 6.6% CAGR during the forecast period (2022-2028).
As HSV infection is more likely to reactivate in the first few months following solid organ and bone marrow transplants, the rise in the number of transplant recipients is a factor in the market's expansion. In accordance with this, researchers are concentrating on creating novel antiviral drugs to increase the range of available treatments for genital and orolabial herpes. Also, they are bringing out antiviral creams or ointments that can lessen HSV-related itching, burning, or tingling sensations, enhance the quality of life (QoL) of patients, and stop infected persons from transmitting the virus.
Many people have HSV that is asymptomatic, which means they carry the virus but have never experienced a herpes outbreak or active episode. Others may occasionally get sores or blisters that are tiny and filled with fluid. These blisters can appear on the hands, fingers, or other body parts but typically on the genitalia, mouth, or lips. The herpes virus can be spread through sexual contact, but other ways exist. Herpes carries a lot of stigmas, yet the virus is fairly widespread. As more people are becoming aware of this, the demand for HSV medication is rising.
LatinAmerica has ahigh HSV-2 seroprevalence. An estimated 20% to 60% of people are infected. Middle-aged Colombian women were found to have the highest HSV-2 frequency in the region. In Brazil, women are more likely to contract HSV-2 if their male partners have a record of anal sex and have had numerous sexual partners during their lifetime. As a result, many regional governments have increased their efforts to mitigate the burden of the disease as well as increase the awareness about it among the general public. The government's provision of HSV treatment at affordable costs is among these efforts. Consequently, such efforts significantly boost the market expansion in this region.
The Brazil market dominated the LAMEA Herpes Simplex Virus Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $47.6 Million by 2028. The Argentina market is experiencing a CAGR of 7.2% during (2022-2028). Additionally, The UAE market would display a CAGR of 6.3% during (2022-2028).
Based on Drug Type, the market is segmented into Valacyclovir, Acyclovir, and Famciclovir. Based on Type, the market is segmented into Herpes simplex virus-1 Infection, and Herpes simplex virus-2 Infection. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Pfizer, Inc., Amneal Pharmaceuticals, Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Glenmark Pharmaceuticals Limited, Fresenius SE & Co. KGaA, Novartis AG, Viatris, Inc., and Emcure Pharmaceuticals Limited.
As HSV infection is more likely to reactivate in the first few months following solid organ and bone marrow transplants, the rise in the number of transplant recipients is a factor in the market's expansion. In accordance with this, researchers are concentrating on creating novel antiviral drugs to increase the range of available treatments for genital and orolabial herpes. Also, they are bringing out antiviral creams or ointments that can lessen HSV-related itching, burning, or tingling sensations, enhance the quality of life (QoL) of patients, and stop infected persons from transmitting the virus.
Many people have HSV that is asymptomatic, which means they carry the virus but have never experienced a herpes outbreak or active episode. Others may occasionally get sores or blisters that are tiny and filled with fluid. These blisters can appear on the hands, fingers, or other body parts but typically on the genitalia, mouth, or lips. The herpes virus can be spread through sexual contact, but other ways exist. Herpes carries a lot of stigmas, yet the virus is fairly widespread. As more people are becoming aware of this, the demand for HSV medication is rising.
LatinAmerica has ahigh HSV-2 seroprevalence. An estimated 20% to 60% of people are infected. Middle-aged Colombian women were found to have the highest HSV-2 frequency in the region. In Brazil, women are more likely to contract HSV-2 if their male partners have a record of anal sex and have had numerous sexual partners during their lifetime. As a result, many regional governments have increased their efforts to mitigate the burden of the disease as well as increase the awareness about it among the general public. The government's provision of HSV treatment at affordable costs is among these efforts. Consequently, such efforts significantly boost the market expansion in this region.
The Brazil market dominated the LAMEA Herpes Simplex Virus Treatment Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $47.6 Million by 2028. The Argentina market is experiencing a CAGR of 7.2% during (2022-2028). Additionally, The UAE market would display a CAGR of 6.3% during (2022-2028).
Based on Drug Type, the market is segmented into Valacyclovir, Acyclovir, and Famciclovir. Based on Type, the market is segmented into Herpes simplex virus-1 Infection, and Herpes simplex virus-2 Infection. Based on Distribution Channel, the market is segmented into Drug Store & Retail Pharmacies, Hospital Pharmacies, and Online Pharmacies. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Abbott Laboratories, Pfizer, Inc., Amneal Pharmaceuticals, Inc., GlaxoSmithKline PLC, Teva Pharmaceuticals Industries Ltd., Glenmark Pharmaceuticals Limited, Fresenius SE & Co. KGaA, Novartis AG, Viatris, Inc., and Emcure Pharmaceuticals Limited.
Scope of the Study
By Drug Type
- Valacyclovir
- Acyclovir
- Famciclovir
By Type
- Herpes simplex virus-1 Infection
- Herpes simplex virus-2 Infection
By Distribution Channel
- Drug Store & Retail Pharmacies
- Hospital Pharmacies
- Online Pharmacies
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Abbott Laboratories
- Pfizer, Inc.
- Amneal Pharmaceuticals, Inc.
- GlaxoSmithKline PLC
- Teva Pharmaceuticals Industries Ltd.
- Glenmark Pharmaceuticals Limited
- Fresenius SE & Co. KGaA
- Novartis AG
- Viatris, Inc.
- Emcure Pharmaceuticals Limited
Unique Offerings
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market Overview
Chapter 3. LAMEA Herpes Simplex Virus Treatment Market by Drug Type
Chapter 4. LAMEA Herpes Simplex Virus Treatment Market by Type
Chapter 5. LAMEA Herpes Simplex Virus Treatment Market by Distribution Channel
Chapter 6. LAMEA Herpes Simplex Virus Treatment Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Abbott Laboratories
- Pfizer, Inc.
- Amneal Pharmaceuticals, Inc.
- GlaxoSmithKline PLC
- Teva Pharmaceuticals Industries Ltd.
- Glenmark Pharmaceuticals Limited
- Fresenius SE & Co. KGaA
- Novartis AG
- Viatris, Inc.
- Emcure Pharmaceuticals Limited
Methodology
LOADING...
Related Reports
From
Herpes Simplex Virus Treatment Global Market Report 2024
- Report
- 200 Pages
- Global
From
Herpes Simplex Virus Treatment Market - Forecasts from 2024 to 2029
- Report
- 140 Pages
- Global
From
From
From
About the Herpes Drug Market
The Herpes Drug market is a subset of the Infectious Diseases Drugs market, which includes drugs used to treat a variety of infectious diseases. Herpes drugs are used to treat the herpes simplex virus (HSV) and its associated conditions, such as genital herpes, cold sores, and shingles. These drugs can be administered orally, topically, or intravenously, depending on the severity of the infection. Commonly prescribed herpes drugs include acyclovir, valacyclovir, and famciclovir. Herpes drugs are Read more
This product is a market research report. Each license type allows a set number of users to access the report. Please select an option from the list below. This product is a market research report. This is a single user license, allowing one user access to the product. The product is a PDF. This product is a market research report. This is a site license, allowing all users within a given geographical location of your organization access to the product. The product is a PDF. This product is a market research report. This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF. 
